| AMB: | Amphotericin B |
| ATCC: | American Type Culture Collection |
| BAL: | Bronchoalveolar lavage |
| c-AmB: | Amphotericin B deoxycholate |
| CAM: | COVID-19-associated mucormycosis |
| CBP: | Clinical breakpoint |
| CI: | Confidence interval |
| CLSI: | Clinical and Laboratory Standards Institute |
| CT: | Computed tomography |
| COVID-19: | Coronavirus disease 2019 |
| DNA: | Deoxyribonucleic acid |
| ECV/ECOFF: | Epidemiological cutoff value |
| EUCAST: | European Committee on Antimicrobial Susceptibility Testing |
| FDG-PET: | Fluorodeoxyglucose positron emission tomography |
| FFPE: | Formalin fixed paraffin-embedded |
| GI: | Gastrointestinal |
| GMS: | Grocott–Gomori methenamine silver |
| H&E: | Haematoxylin and eosin |
| HRMA: | High-resolution melting analysis |
| IA: | Invasive aspergillosis |
| ICU: | Intensive care unit |
| IHC: | Immunohistochemistry |
| ITS: | Internal transcribed spacer |
| L-AmB: | Liposomal Amphotericin B |
| LFIA: | Lateral flow immunoassay |
| MALDI TOF | Matrix assisted laser desorption ionisation-time of flight |
| MIC: | Minimum inhibitory concentration |
| MRI: | Magnetic Resonance Imaging |
| PAS: | Periodic acid-Schiff |
| PCR: | Polymerase chain reaction |
| POS: | Posaconazole |
| RNA: | Ribonucleic acid |
| ROCM: | Rhino-orbital-cerebral mucormycosis |
| SNP: | Single nucleotide polymorphism |
| TDM: | Therapeutic drug monitoring |
| ITR: | Itraconazole |
| WGS: | Whole genome sequencing |